Kappa Bioscience

You are here >Portfolio

Portfolio

Encap turns your mobile phone into a user authentication device, replacing the electronic code calculator used when logging into your online bank or enterprise VPN. Encap’s solution is cost-effective for banks and user-friendly for customers, while maintaining the highest level of security.

iDTEQ has developed unique alarm sensors utilizing artificial intelligence and infrasound detection. The sensors are targeted at securing vehicles and buildings from intrusion. iDTEQ’s sensors reduce false alarms and increases detection of actual break-ins.

Lauras is a biotech company developing drugs for immunostimulating therapy in HIV/AIDS and other immune diseases based on proprietary technology.

OstomyCure is a medical technology company developing an innovative new solution for evacuating fluids from the intestines using a titanium implant. The TIES® technology (Transcutaneous Implant Evacuation System) will present an alternative for patients with inflammatory conditions in colon, cancer in the urinary bladder, and cancer in rectum – patients that presently often need to wear a stoma bag on a permanent basis. The TIES® technology will dramatically improve the quality of life for stoma patients since it offers a stoma bag-free life.

www.ostomycure.no

Promon develops software solutions for the mainstream enterprise security market as well as for companies and organizations having especially demanding security requirements. Promon's security solutions are different from and more powerful than regular virus protection software. Promon software detects and protects against both known and unknown data viruses. Promon's methods are a new invention and are patent pending.

Searchdaimon has developed proprietary technology and products for enterprise search. The product portfolio includes search solutions for Software as a Service-providers as well as appliances for enterprise search.

www.searchdaimon.com

Setred provides a unique new 3D display technology that gives the user a full 3D experience without the use of goggles, headgear or RF transmitters. Setred’s displays can be integrated with any source of 3D data, such as medical equipment, gaming applications and geophysical/seismic tools. Setred’s technology is protected by several patents/patents pending.

siRNAsense focuses on the first critical steps in development of RNAi therapeutics within the fields of cancer and neuroscience. siRNA is a new class of drug candidates that are applicable to a broad range of different indications, each of which has its own challenges for therapeutics development.

www.sirnasense.com

Kappa Bioscience has developed a new proprietary production process for vitamin K2 MK-7, which means Kappa can deliver vitamin K2 at a competitive price, with higher purity and in higher concentrations than the vitamin K2 commercially available today. There is an ever-growing body of science supporting the benefits of vitamin K2, most well established for bone and cardiovascular health. Emerging evidence also supports a potential role for reducing the risk of prostate cancer.

XT Software has developed energyXT, a music creation software that is lightweight, easy to use and can be adapted to various platforms. The software is distributed both online and in stores worldwide through partners.

www.energy-xt.com

Eureka develops reverse osmosis desalination plants based upon innovative designs and intelligent use of materials. Key components of Eureka’s plant have been patented.

Protia develops unique ceramic proton conductors based upon research at the Norwegian University of Science and Technology and the University of Oslo. The company is focused on conversion of natural gas to clean synthetic fuels (GTL) for lower carbon emissions and greater economic value to countries and companies with gas reserves.

BMI is an incubator for biomedical start-ups, cooperating closely with Medinnova, the TTO for several of the countrys leading hospitals such as Rikshospitalet-Radiumhospitalet and Ullevål University hospital.